4.01
Schlusskurs vom Vortag:
$3.91
Offen:
$3.91
24-Stunden-Volumen:
636.39K
Relative Volume:
1.08
Marktkapitalisierung:
$123.03M
Einnahmen:
$875.70K
Nettoeinkommen (Verlust:
$-39.57M
KGV:
-2.9874
EPS:
-1.3423
Netto-Cashflow:
$-33.65M
1W Leistung:
+1.26%
1M Leistung:
+18.29%
6M Leistung:
+79.82%
1J Leistung:
+32.78%
Vistagen Therapeutics Inc Stock (VTGN) Company Profile
Firmenname
Vistagen Therapeutics Inc
Sektor
Branche
Telefon
650-577-3600
Adresse
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie VTGN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
VTGN
Vistagen Therapeutics Inc
|
4.01 | 119.96M | 875.70K | -39.57M | -33.65M | -1.3423 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-12-07 | Hochstufung | Jefferies | Hold → Buy |
2023-08-07 | Hochstufung | Maxim Group | Hold → Buy |
2022-07-22 | Herabstufung | Jefferies | Buy → Hold |
2022-07-22 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2022-07-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
2021-05-20 | Eingeleitet | Robert W. Baird | Outperform |
2021-02-18 | Eingeleitet | Jefferies | Buy |
2021-01-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
2018-06-27 | Eingeleitet | Maxim Group | Buy |
2018-02-08 | Bestätigt | Chardan Capital Markets | Buy |
2017-03-28 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Vistagen Therapeutics Inc Aktie (VTGN) Neueste Nachrichten
Will Vistagen Therapeutics Inc. stock gain from strong economyMarket Movement Recap & Expert Approved Momentum Ideas - newser.com
Tools to assess Vistagen Therapeutics Inc.’s risk profileJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com
What institutional flow reveals about Vistagen Therapeutics Inc.July 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
How to recover losses in Vistagen Therapeutics Inc. stockPortfolio Return Report & Free Technical Confirmation Trade Alerts - newser.com
Vistagen Therapeutics Inc. stock momentum explainedWeekly Loss Report & High Return Stock Watch Alerts - newser.com
Combining machine learning predictions for Vistagen Therapeutics Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
Applying Elliott Wave Theory to Vistagen Therapeutics Inc.Quarterly Trade Review & Weekly Market Pulse Updates - newser.com
VistaGen Therapeutics’ (VTGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
Published on: 2025-10-10 09:33:10 - newser.com
Using Ichimoku Cloud for Vistagen Therapeutics Inc. technicalsExit Point & Intraday High Probability Setup Alerts - newser.com
Published on: 2025-10-10 04:25:39 - newser.com
VistaGen Therapeutics (NASDAQ:VTGN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
What MACD and RSI say about Vistagen Therapeutics Inc.July 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com
We Think Vistagen Therapeutics (NASDAQ:VTGN) Needs To Drive Business Growth Carefully - Sahm
Advanced analytics toolkit walkthrough for Vistagen Therapeutics Inc.July 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com
High Stakes Ahead: Vistagen's Fasedienol Trials Could Make Or Break The Story - RTTNews
Sector ETF performance correlation with Vistagen Therapeutics Inc.July 2025 Closing Moves & High Yield Stock Recommendations - newser.com
How moving averages guide Vistagen Therapeutics Inc. trading2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com
Detecting price anomalies in Vistagen Therapeutics Inc. with AIMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Has Vistagen Therapeutics Inc. found a price floorJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com
Understanding Vistagen Therapeutics Inc.’s price movement2025 Top Decliners & Verified Stock Trade Ideas - newser.com
Full technical analysis of Vistagen Therapeutics Inc. stockJuly 2025 Setups & Entry and Exit Point Strategies - newser.com
Vistagen Therapeutics Inc. stock daily chart insightsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
What’s the recovery path for long term holders of Vistagen Therapeutics Inc.Share Buyback & Verified Momentum Stock Watchlist - newser.com
How high can Vistagen Therapeutics Inc. stock go2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com
Vistagen Therapeutics Inc Stock Analysis and ForecastHigh Frequency Trading Trends & Access High Yield Alerts - earlytimes.in
Acute Social Anxiety Disorder Market on Track for Major Expansion by 2034, According to DelveInsight | GlaxoSmithKline Plc, Viatris Inc, Johnson & Johnson, Novartis AG, Pfizer Inc, AstraZeneca Plc - Barchart.com
Tools to monitor Vistagen Therapeutics Inc. recovery probabilityWatch List & Target Return Focused Picks - newser.com
Finanzdaten der Vistagen Therapeutics Inc-Aktie (VTGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):